Clinical trial
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients With (MCMD)
NCT00459693 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients With (MCMD)
- Lead sponsor
- National Institute of Mental Health (NIMH)
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 9, 2007
- Completion date
- April 6, 2014
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aids dementia complex, aids encephalopathy, aids-related dementia complex, healthy, hiv infections, hiv-associated cognitive motor complex, hiv-dementia